What are McKesson's primary business segments and revenue drivers?

McKesson Corporation's primary business revolves around the distribution of pharmaceuticals, medical supplies, and health and beauty care products. Its revenue is driven by sales to a diverse customer base including retail pharmacies, hospitals, health systems, and other healthcare providers.

What is the company's financial health and performance as of March 30, 2004?

Based on the 2004 10-K filing, McKesson demonstrated strong revenue performance. While specific figures require a deeper dive into the financial statements, the overall context suggests a company with substantial sales and an established market position.

What are the key risks and legal matters McKesson is facing?

The report likely discusses various operational, regulatory, and market risks inherent in the healthcare distribution industry. Specific legal proceedings and their potential impact are also typically disclosed in such filings, offering insights into contingent liabilities or ongoing disputes.

How does McKesson manage its market risk?

McKesson's approach to market risk management would likely involve strategies to mitigate exposure to fluctuations in interest rates, foreign currency exchange rates, and commodity prices, particularly as they relate to its significant international operations and treasury activities.

MCK 10-K FY2004 Annual Report — Revenue, Net Income, EPS

Summary

McKesson Corporation's 2004 Form 10-K report details a significant year for the company, characterized by robust revenue growth and strategic positioning within the healthcare distribution sector. The company appears to be leveraging its scale and operational efficiency to navigate a dynamic market. Investors should note the company's primary business segments, which are crucial to understanding its revenue streams and competitive advantages. The report also sheds light on the company's financial health, operational strategies, and risk management practices, providing a comprehensive overview of its performance and outlook.

Key Highlights

1McKesson Corporation operates as a leading distributor of pharmaceuticals and healthcare products, demonstrating significant market presence.
2The company's business model is built on efficient supply chain management and a broad customer base across various healthcare segments.
3Financial performance indicates substantial revenue generation, reflecting strong demand for its services.
4The report touches upon key operational aspects, including logistics, technology, and customer service, which are critical to its value proposition.
5Risk management and legal proceedings are addressed, providing insight into potential challenges and the company's preparedness.
6Executive compensation structures are detailed, offering transparency into management incentives.

MCKESSON CORP Annual Report, Year Ended Mar 31, 2004

Summary

Key Highlights

Frequently Asked Questions